Trial intelligence / Profile preview

Bezafibrate in early-stage primary biliary cholangitis with incomplete response to UDCA

2011-004681-15Phase 3Completed

Sponsor
Medical University of Graz
Start
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of bezafibrate in primary biliary cholangitis (PBC), sponsored by Medical University of Graz. Primary endpoint: alkaline phosphatase. Started Oct 2011; status: completed.

02

Drugs

bezafibrate
03

Conditions

primary biliary cholangitis (PBC)

Beyond the preview

Go deeper on 2011-004681-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-004681-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call